Paris, France
24-28 February 2012
Paris, France 2012
Willy Gregoir Medal 2012
M.J. Marberger,
Vienna (AT)
Crystal Matula Award 2012
P.J. Bastian,
Düsseldorf (DE)
Frans Debruyne Life Time Achievement Award 2012
R.E. Hautmann,
Neu-Ulm (DE)
Innovators in Urology Award 2012
J.E.A. Wickham,
Dorking (GB)
Claude Abbou
27th Annual EAU Congress
24-28 February 2012
Paris, France
Facts & Figures
12,989 participants
3,700 abstract submitted, 1,161 accepted
40 ESU Courses
Environmentally friendly
Keeping up with the latest trends, the EAU moved forward with digital technology solutions for the convenience of its members. According to the yearly poll, almost 15,000 visitors followed the congress online, especially from mobile devices, and almost 40% used the Congress App exclusively. This digital step made the 27th Annual EAU Congress more environmentally friendly, and it also helped the EAU reduce costs and make greater strides towards digital platforms to share urological knowledge.
Focus on uro-oncology
Plenary sessions highlighted major issues in onco-urology and re-examined standard surgical procedures for bladder and prostate cancers. Organ preservation and quality-of-life issues were recurring topics that were raised regarding the critique on radical surgical treatment. Screening for prostate cancer remained a favored topic in the closing scientific session with a presentation of an ESRPC study update that examined the benefits and drawbacks of PSA testing, early PCa diagnosis and radical treatment.
Renewed international impulse
International ties with urological organisations are fundamental for urological advancement. During the congress in Paris, the EAU welcomed delegates from 118 countries, 30 more nationalities than in previous years, making it a truly international urological forum.
Launch of the EAU Resource Center
Together with the Congress App, the EAU innovated in the field of tech solutions with its Resource Center search tool. It became easier for all delegates to see the presentations, abstracts, webcasts and posters of the congress, and search through the archives, to find specific information with just a few clicks.
Paris, France 1996
Paris, France
1-4 September 1996
Willy Gregoir Medal 1996
A. Steg,
Paris (FR)
Crystal Matula Award 1996
F.C. Hamdy,
Oxford (GB)
Alain Le Duc
12th EAU Congress
1-4 September 1996
Paris, France
Facts & Figures
4,800 participants
800 papers selected for the Scientific sessions and 500 poster resentations were on display as well as a range of video presentations showing various surgical techniques.
The first time 6 ESU Courses were organised
Chair of the Scientific Committee: Prof. Laurent Boccon-Gibod
The First Crystal Matula Award was granted to Prof. Freddie Hamdy, Sheffield (GB)
At the General Assembly the new structure of the EAU with various new committees for all the new activities were approved. From that moment on the EAU grew at tremendous in terms of membership, congress participants as well as activities.
French virologist Prof. Luc Montagnier, who later received the 2008 Nobel Prize for Medicine as co-winner for his discovery of the Human Immunodeficiency Virus (HIV), outlined treatment procedures in a state-of-the art lecture given during the this Congress in Paris.
Paris, France 2006
Paris, France
5-8 April 2006
Willy Gregoir Medal 2006
A. Borkowski,
Warsaw (PL)
Crystal Matula Award 2006
A. De La Taille,
Creteil (FR)
Frans Debruyne Life Time Achievement Award 2006
C.C. Schulman,
Brussels (BE)
Laurent Boccon-Gibod
21st Annual EAU Congress
5-8 April 2006
Paris, France
Facts & Figures
11,565 participants
2,647 abstracts submitted, 1,209 selected
34 ESU Courses organised
The 21st Annual EAU Congress in Paris marked one of the biggest surge in terms of attendance and participation in the EAU congresses, nearly doubling the attendance in 2005. Complementing this growth was the rise in the number of submitted abstracts and a wider coverage of urological topics.
Focus on best practices
Some of the major topics taken up during the plenary sessions included the contemporary management of prostate cancer, the developments of angiogenesis inhibitors for stopping tumour cell growth and the latest developments for the treatment of Lower Urinary Track Syndrome (LUTS). Panel discussions, debates and open forums and lectures focusing on prostate cancer diagnosis
exhib opening teillac BC
